Screening of donor and recipient prior to solid organ transplantation

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Fischer, S A ^a   Avery, R K ^b  

^a BROWN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Donor selection; Infection; Living donors; Tissue and organ procurement

Indexed keywords

ADEFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BCG VACCINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; ISONIAZID; IVERMECTIN; LAMIVUDINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; PYRROLE DERIVATIVE; RIFAMPICIN; TENOFOVIR; TIABENDAZOLE; TUBERCULIN; VARICELLA ZOSTER VACCINE;

ACID FAST BACTERIUM; ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ANTIVIRAL RESISTANCE; ASPERGILLUS; ASSISTED CIRCULATION; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BCG VACCINATION; BLOOD CULTURE; CADAVER DONOR; COCCIDIOIDOMYCOSIS; CYTOMEGALOVIRUS; DEVICE INFECTION; DONOR SELECTION; EPSTEIN BARR VIRUS; FALSE POSITIVE RESULT; GRAFT RECIPIENT; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HYGIENE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; LIVING DONOR; LUNG INFECTION; LUNG TRANSPLANTATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEDICAL SOCIETY; MYCOBACTERIOSIS; MYCOSIS; ORGAN DONOR; ORGAN TRANSPLANTATION; PARASITOSIS; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RABIES VIRUS; REVIEW; SCREENING; SEROCONVERSION; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; STAIN; SYPHILIS; TOXOPLASMOSIS; URINE CULTURE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

HUMANS; INFECTION; TISSUE DONORS; TRANSPLANTATION;

EID: 72949087576     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02888.x     Document Type: Review

References (87)

1. Avery RK. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 2002 35 : 1513 1519.
2. Avery RK. Prophylactic strategies before solid-organ transplantation. Curr Opin Infect Dis 2004 17 : 353 356.
3. Delmonico FL. Cadaver donor screening for infectious agents in solid organ transplantation. Clin Infect Dis. 2000 31 : 781 786.
4. Delmonico FL, Snydman DR. Organ donor screening for infectious diseases: Review of practice and implications for transplantation. Transplantation 1998 65 : 603 610.
5. Gottesdiener KM. Transplanted infections: Donor-to-host transmission with the allograft. Ann Intern Med 1989 110 : 1001 1016.
6. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 2001 33 (Suppl 1 S15 21.
7. Schaffner A. Pretransplant evaluation for infections in donors and recipients of solid organs. Clin Infect Dis 2001 33 (Suppl 1 S9 14.
8. Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 2001 1 (Suppl 2 3 95.
9. Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. The evaluation of living renal transplant donors: Clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1996 7 : 2288 2313.
10. Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002 2 : 701 711.
11. Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 2001 1 : 185 191.
12. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000 49 : 1 125, CE121 127.
13. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994 43 : 1 17.
14. Srinivasan A, Burton EC, Kuehnert MJ et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005 352 : 1103 1111. (Pubitemid 40365351)
15. Fischer SA, Graham MB, Kuehnert MJ et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006 354 : 2235 2249.
16. Iwamoto M, Jernigan DB, Guasch A et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003 348 : 2196 2203.
17. Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992 326 : 726 732.
18. Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008 358 : 2832 2837.
19. Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008 14 : 1603 1608.
20. Tugwell BD, Patel PR, Williams IT et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005 143 : 648 654.
21. Fishman JA, Strong DM, Kuehnert MJ. Organ and tissue safety workshop 2007: Advances and challenges. Cell Tissue Bank 2008 10 : 271 280.
22. Fishman JA, Greenwald MA, Kuehnert MJ. Enhancing transplant safety: A new era in the microbiologic evaluation of organ donors? Am J Transplant 2007 7 : 2652 2654.
23. Humar A, Fishman JA. Donor-derived infection: Old problem, new solutions? Am J Transplant 2008 8 : 1087 1088.
24. Caballero F, Domingo P, Rabella N, Lopez-Navidad A. Successful transplantation of organs retrieved from a donor with syphilis. Transplantation 1998 65 : 598 599.
25. Doig RL, Boyd PJ, Eykyn S. Staphylococcus aureus transmitted in transplanted kidneys. Lancet 1975 2 : 243 245.
26. Kumar D, Cattral MS, Robicsek A, Gaudreau C, Humar A. Outbreak of pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation 2003 75 : 1053 1055.
27. Fernando ON, Higgins AF, Moorhead JF. Letter: Secondary haemorrhage after renal transplantation. Lancet 1976 2 : 368.
28. Nelson PW, Delmonico FL, Tolkoff-Rubin NE et al. Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984 37 : 313 314.
29. Freeman RB, Giatras I, Falagas ME et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999 68 : 1107 1111.
30. Lopez-Navidad A, Domingo P, Caballero F, Gonzalez C, Santiago C. Successful transplantation of organs retrieved from donors with bacterial meningitis. Transplantation 1997 64 : 365 368.
31. Ruiz I, Gavalda J, Monforte V et al. Donor-to-host transmission of bacterial and fungal infections in lung transplantation. Am J Transplant 2006 6 : 178 182.
32. McCoy GC, Loening S, Braun WE, Magnusson MO, Banowsky LH, McHenry MC. The fate of cadaver renal allografts contaminated before transplantation. Transplantation 1975 20 : 467 472.
33. Mossad SB, Avery RK, Goormastic M, Hobbs RE, Stewart RW. Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation. Transplantation 1997 64 : 1209 1210.
34. Matignon M, Botterel F, Audard V et al. Outcome of renal transplantation in eight patients with Candida sp. contamination of preservation fluid. Am J Transplant 2008 8 : 697 700.
35. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998 27 : 1266 1277.
36. Manuel O, Humar A, Preiksaitis J et al. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007 7 : 2797 2801.
37. Hernandez-Hernandez E, Alberu J, Gonzalez-Michaca L et al. Screening for tuberculosis in the study of the living renal donor in a developing country. Transplantation 2006 81 : 290 292.
38. Antony SJ, Ynares C, Dummer JS. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant 1997 11 : 34 37.
39. Limaye AP, Connolly PA, Sagar M et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000 343 : 1163 1166.
40. Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002 73 : 306 308.
41. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001 33 : 1536 1544.
42. Wreghitt TG, Gray JJ, Pavel P et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992 5 : 197 200.
43. Rogers NM, Peh CA, Faull R, Pannell M, Cooper J, Russ GR. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transpl Infect Dis 2008 10 : 71 74.
44. Gourishankar S, Doucette K, Fenton J, Purych D, Kowalewska-Grochowska K, Preiksaitis J. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation 2008 85 : 980 985.
45. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006 55 : 798 800.
46. Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med 1997 126 : 275 279.
47. Falagas ME, Snydman DR, Griffith J, Werner BG, Freeman R, Rohrer R. Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis 1997 25 : 314 317.
48. Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG. Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005 143 : 870 880.
49. Green M, Cacciarelli TV, Mazariegos GV et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation 1998 66 : 1641 1644.
50. Preiksaitis JK, Keay S. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 2001 33 (Suppl 1 S38 46.
51. McDiarmid SV, Jordan S, Kim GS et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998 66 : 1604 1611.
52. Dockrell DH, Mendez JC, Jones M et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999 67 : 399 403.
53. Regamey N, Tamm M, Wernli M et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998 339 : 1358 1363.
54. Gomez-Roman JJ, Ocejo-Vinyals JG, Sanchez-Velasco P, Leyva-Cobian F, Val-Bernal JF. Presence of human herpesvirus 8 DNA sequences in renal transplantation-associated pleural Kaposi sarcoma. Arch Pathol Lab Med 1999 123 : 1269 1273.
55. Kapelushnik J, Ariad S, Benharroch D et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol 2001 113 : 425 428.
56. Wachs ME, Amend WJ, Ascher NL et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995 59 : 230 234.
57. Madayag RM, Johnson LB, Bartlett ST et al. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 1997 64 : 1781 1786.
58. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999 68 : 1058 1061.
59. Younossi ZM, Braun WE, Protiva DA, Gifford RW Jr., Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. Transplantation 1999 67 : 272 275.
60. Lee WC, Wu MJ, Cheng CH, Chen CH, Shu KH, Lian JD. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001 38 : 1074 1081.
61. Pereira BJ, Natov SN, Bouthot BA et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998 53 : 1374 1381.
62. Abbott KC, Bucci JR, Matsumoto CS et al. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003 14 : 2908 2918.
63. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Peters TG, Schnitzler MA. The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant 2004 4 : 2032 2037.
64. Bucci JR, Lentine KL, Agodoa LY, Peters TG, Schnitzler MA, Abbott KC. Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: Analysis of the USRDS/UNOS database. In : Cecka JM and Terasaki, PI, eds. Clinical Transplants. Los Angeles, CA : Terasaki Foundation Laboratory 2004 : 51 61.
65. Cotler SJ, Jensen DM, Kesten S. Hepatitis C virus infection and lung transplantation: A survey of practices. J Heart Lung Transplant 1999 18 : 456 459.
66. Lake KD, Smith CI, LaForest SK, Allen J, Pritzker MR, Emery RW. Policies regarding the transplantation of hepatitis C-positive candidates and donor organs. J Heart Lung Transplant 1997 16 : 917 921.
67. Ong JP, Barnes DS, Younossi ZM et al. Outcome of de novo hepatitis C virus infection in heart transplant recipients. Hepatology 1999 30 : 1293 1298.
68. Roland ME, Barin B, Carlson L et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008 8 : 355 365.
69. Shames BD, D'Alessandro AM, Sollinger HW. Human T-cell lymphotrophic virus infection in organ donors: A need to reassess policy? Am J Transplant 2002 2 : 658 663.
70. Toro C, Rodes B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003 75 : 102 104.
71. Zarranz Imirizaldu JJ, Gomez Esteban JC, Rouco Axpe I et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 2003 74 : 1080 1084.
72. Gonzalez-Perez MP, Munoz-Juarez L, Cardenas FC, Zarranz Imirizaldu JJ, Carranceja JC, Garcia-Saiz A. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation 2003 75 : 1006 1011.
73. Nakamura N, Tamaru S, Ohshima K, Tanaka M, Arakaki Y, Miyauchi T. Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc 2005 37 : 1779 1782.
74. Fischer SA. Emerging viruses in transplantation: There is more to infection after transplant than CMV and EBV. Transplantation 2008 86 : 1327 1339.
75. Kumar D, Humar A. Emerging viral infections in transplant recipients. Curr Opin Infect Dis 2005 18 : 337 341.
76. Natov SN, Pereira BJ. Transmission of viral hepatitis by kidney transplantation: Donor evaluation and transplant policies (Part 1: hepatitis B virus). Transpl Infect Dis 2002 4 : 117 123.
77. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion-Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002 51 : 879.
78. Kiberd BA, Forward K. Screening for West Nile virus in organ transplantation: A medical decision analysis. Am J Transplant 2004 4 : 1296 1301.
79. Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation-Massachusetts, 2008. MMWR Morb Mortal Wkly Rep 2008 57 : 799 801.
80. Update: Interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents. MMWR Morb Mortal Wkly Rep 2005 54 : 799 801.
81. Palacios G, Druce J, Du L et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008 358 : 991 998.
82. Kusne S, Smilack J. Transmission of rabies virus from an organ donor to four transplant recipients. Liver Transpl 2005 11 : 1295 1297.
83. Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003 3 : 977 981.
84. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: Implications for permanent use of the device. Ann Thorac Surg 1996 61 : 359 365 discussion 372-353.
85. Avery RK. Infections after lung transplantation. Semin Respir Crit Care Med 2006 27 : 544 551.
86. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001 164 : 2102 2106.
87. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 52 : 15 18.